Related Experiment Video
Updated: Feb 28, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Diabetes Mellitus Is an Independent Predictor of Short-Term Mortality in Critically Ill ICU Patients
Mădălina Diana Daina Fehér1, Codrin Dan Nicolae Ilea2, Cosmin Mihai Vesa3
1Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410081 Oradea, Romania.
Abstract:
Background: Diabetes mellitus (DM) is frequently encountered in critically ill patients and has been associated with poor outcomes. However, its independent impact on short-term mortality in heterogeneous ICU populations remains unclear. Objectives: To evaluate whether diabetes mellitus is an independent risk factor for intensive care unit (ICU) mortality in critically ill adult patients. Methods: We conducted a single-center retrospective observational study including adult patients admitted to the ICU between January and December 2024. Patients were stratified according to the presence or absence of diabetes mellitus. Demographic data, major clinical variables, and ICU outcomes were analyzed. The primary endpoint was ICU mortality. A multivariate logistic regression model was used to identify independent predictors of death. Results: A total of 1344 patients were included, of whom 435 (32.4%) had diabetes mellitus. ICU mortality was significantly higher in patients with DM compared to non-diabetic patients (54.9% vs. 46.3%, p = 0.004). After adjustment for age, sex, sepsis, acute kidney injury, and mechanical ventilation, diabetes mellitus remained independently associated with an increased risk of ICU death. Conclusions: Diabetes mellitus is an independent predictor of short-term mortality in critically ill ICU patients. Early identification and risk stratification of diabetic patients may improve clinical management and outcomes in intensive care settings.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
